| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adipocytes | 23 | 2015 | 169 | 3.530 |
Why?
|
| Glycogen | 17 | 2016 | 59 | 3.130 |
Why?
|
| Obesity | 14 | 2022 | 1019 | 2.030 |
Why?
|
| Adipose Tissue | 10 | 2020 | 270 | 1.680 |
Why?
|
| Insulin Resistance | 8 | 2019 | 379 | 1.530 |
Why?
|
| Glycogen Synthase | 12 | 2016 | 22 | 1.230 |
Why?
|
| Insulin | 17 | 2013 | 1185 | 1.220 |
Why?
|
| Bariatric Surgery | 3 | 2019 | 208 | 1.190 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 8 | 2016 | 392 | 1.060 |
Why?
|
| Glucose | 14 | 2014 | 692 | 0.930 |
Why?
|
| Circadian Rhythm | 2 | 2019 | 285 | 0.930 |
Why?
|
| Weight Loss | 3 | 2019 | 234 | 0.920 |
Why?
|
| Lipid Metabolism | 6 | 2013 | 214 | 0.850 |
Why?
|
| Protein Phosphatase 1 | 8 | 2010 | 31 | 0.850 |
Why?
|
| Adipogenesis | 3 | 2009 | 41 | 0.800 |
Why?
|
| Liver | 5 | 2013 | 1207 | 0.790 |
Why?
|
| Fructose | 2 | 2022 | 36 | 0.760 |
Why?
|
| Energy Metabolism | 7 | 2022 | 299 | 0.760 |
Why?
|
| Mice | 37 | 2022 | 12233 | 0.720 |
Why?
|
| Diabetes, Gestational | 1 | 2022 | 49 | 0.710 |
Why?
|
| Endocrine System | 2 | 2013 | 16 | 0.700 |
Why?
|
| Hypoglycemia | 1 | 2022 | 113 | 0.700 |
Why?
|
| Animals | 51 | 2022 | 28041 | 0.680 |
Why?
|
| Phosphoprotein Phosphatases | 9 | 2016 | 58 | 0.680 |
Why?
|
| Gene Expression | 5 | 2019 | 1301 | 0.630 |
Why?
|
| Glycogenolysis | 2 | 2010 | 2 | 0.620 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2019 | 296 | 0.610 |
Why?
|
| Incretins | 1 | 2019 | 15 | 0.590 |
Why?
|
| Bone Remodeling | 1 | 2019 | 21 | 0.590 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2019 | 48 | 0.590 |
Why?
|
| Eating | 3 | 2022 | 162 | 0.590 |
Why?
|
| Diet | 1 | 2022 | 460 | 0.580 |
Why?
|
| Bone and Bones | 1 | 2019 | 269 | 0.530 |
Why?
|
| Adiposity | 2 | 2017 | 76 | 0.500 |
Why?
|
| Adipose Tissue, Brown | 2 | 2016 | 96 | 0.500 |
Why?
|
| Uncoupling Protein 1 | 1 | 2016 | 44 | 0.480 |
Why?
|
| Starvation | 1 | 2016 | 22 | 0.480 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 1516 | 0.470 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2016 | 111 | 0.470 |
Why?
|
| Receptors, Glucocorticoid | 3 | 2015 | 144 | 0.470 |
Why?
|
| Mammary Glands, Animal | 5 | 2020 | 81 | 0.450 |
Why?
|
| Endocrine Disruptors | 2 | 2013 | 28 | 0.440 |
Why?
|
| Aniline Compounds | 2 | 2013 | 62 | 0.440 |
Why?
|
| Sleep Deprivation | 2 | 2013 | 125 | 0.440 |
Why?
|
| 3T3-L1 Cells | 8 | 2013 | 35 | 0.440 |
Why?
|
| Insulin Receptor Substrate Proteins | 3 | 2013 | 56 | 0.430 |
Why?
|
| Diet, High-Fat | 4 | 2020 | 135 | 0.420 |
Why?
|
| Thermogenesis | 2 | 2013 | 46 | 0.410 |
Why?
|
| Mice, Inbred C57BL | 10 | 2022 | 3430 | 0.400 |
Why?
|
| Adipose Tissue, White | 1 | 2013 | 28 | 0.390 |
Why?
|
| Leptin | 7 | 2022 | 100 | 0.390 |
Why?
|
| Growth Hormone | 1 | 2013 | 97 | 0.390 |
Why?
|
| Catecholamines | 1 | 2013 | 91 | 0.390 |
Why?
|
| Sulfonamides | 2 | 2013 | 331 | 0.380 |
Why?
|
| Receptor, Insulin | 3 | 2012 | 60 | 0.370 |
Why?
|
| Phosphoenolpyruvate Carboxylase | 1 | 2012 | 2 | 0.370 |
Why?
|
| Dioxins | 1 | 2012 | 2 | 0.370 |
Why?
|
| Phosphorylation | 9 | 2016 | 1130 | 0.370 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2012 | 9 | 0.370 |
Why?
|
| Triglycerides | 2 | 2010 | 231 | 0.360 |
Why?
|
| Models, Biological | 5 | 2016 | 1768 | 0.360 |
Why?
|
| Signal Transduction | 12 | 2019 | 3498 | 0.350 |
Why?
|
| Adrenal Gland Neoplasms | 2 | 2009 | 83 | 0.340 |
Why?
|
| Thyroid Hormones | 1 | 2013 | 350 | 0.330 |
Why?
|
| Fatty Acids | 4 | 2018 | 145 | 0.320 |
Why?
|
| Mice, Transgenic | 10 | 2018 | 1584 | 0.320 |
Why?
|
| Muscle, Skeletal | 4 | 2008 | 474 | 0.320 |
Why?
|
| Hepatocytes | 6 | 2012 | 129 | 0.320 |
Why?
|
| Liver Glycogen | 1 | 2009 | 5 | 0.300 |
Why?
|
| Sleep Wake Disorders | 1 | 2010 | 124 | 0.290 |
Why?
|
| Humans | 33 | 2022 | 93607 | 0.290 |
Why?
|
| Protein Transport | 3 | 2013 | 438 | 0.280 |
Why?
|
| Cells, Cultured | 11 | 2021 | 2828 | 0.280 |
Why?
|
| Glycogen Phosphorylase | 4 | 2016 | 6 | 0.260 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2007 | 3 | 0.260 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2014 | 1231 | 0.250 |
Why?
|
| Positron-Emission Tomography | 1 | 2009 | 350 | 0.250 |
Why?
|
| Carcinogenesis | 2 | 2020 | 235 | 0.250 |
Why?
|
| Hypoglycemic Agents | 3 | 2005 | 379 | 0.240 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2020 | 190 | 0.240 |
Why?
|
| Male | 22 | 2021 | 44578 | 0.230 |
Why?
|
| Chelating Agents | 1 | 2005 | 68 | 0.230 |
Why?
|
| Organometallic Compounds | 2 | 2005 | 139 | 0.220 |
Why?
|
| Dietary Fats | 2 | 2017 | 135 | 0.220 |
Why?
|
| 3T3 Cells | 5 | 2009 | 94 | 0.210 |
Why?
|
| Macrophages | 3 | 2020 | 610 | 0.210 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2016 | 129 | 0.200 |
Why?
|
| Gene Expression Regulation | 7 | 2020 | 1980 | 0.200 |
Why?
|
| Mammary Neoplasms, Animal | 3 | 2020 | 58 | 0.200 |
Why?
|
| Phosphoproteins | 1 | 2004 | 259 | 0.200 |
Why?
|
| Weight Gain | 2 | 2022 | 128 | 0.200 |
Why?
|
| Peptide Elongation Factor 2 | 1 | 2003 | 13 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2013 | 364 | 0.190 |
Why?
|
| Fasting | 3 | 2013 | 164 | 0.190 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2012 | 1913 | 0.190 |
Why?
|
| Female | 17 | 2022 | 48771 | 0.190 |
Why?
|
| Hunger | 1 | 2022 | 20 | 0.190 |
Why?
|
| Mesentery | 2 | 2020 | 46 | 0.190 |
Why?
|
| Nerve Growth Factors | 2 | 1993 | 53 | 0.180 |
Why?
|
| Lactic Acid | 3 | 2012 | 104 | 0.180 |
Why?
|
| Overweight | 1 | 2022 | 120 | 0.170 |
Why?
|
| Adipokines | 2 | 2019 | 18 | 0.170 |
Why?
|
| Serum Albumin | 1 | 2002 | 124 | 0.170 |
Why?
|
| Gluconeogenesis | 3 | 2012 | 15 | 0.170 |
Why?
|
| Carrier Proteins | 2 | 2006 | 660 | 0.170 |
Why?
|
| Laminin | 1 | 2021 | 89 | 0.170 |
Why?
|
| Bacterial Translocation | 1 | 2020 | 26 | 0.160 |
Why?
|
| Diet, Fat-Restricted | 2 | 2018 | 30 | 0.160 |
Why?
|
| Needle-Exchange Programs | 1 | 2020 | 19 | 0.160 |
Why?
|
| Inflammation | 3 | 2015 | 1049 | 0.160 |
Why?
|
| Adenosine Triphosphate | 3 | 2012 | 315 | 0.150 |
Why?
|
| Arteries | 1 | 2020 | 171 | 0.150 |
Why?
|
| Gene Silencing | 3 | 2010 | 177 | 0.150 |
Why?
|
| Infant, Newborn | 2 | 2022 | 2482 | 0.150 |
Why?
|
| Reference Standards | 1 | 2019 | 146 | 0.150 |
Why?
|
| Rats | 7 | 2018 | 4042 | 0.140 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2020 | 98 | 0.140 |
Why?
|
| Fertility | 1 | 2019 | 119 | 0.140 |
Why?
|
| Protein Subunits | 3 | 2009 | 120 | 0.140 |
Why?
|
| Energy Intake | 2 | 2022 | 97 | 0.140 |
Why?
|
| Adenoviridae | 4 | 2010 | 340 | 0.140 |
Why?
|
| Young Adult | 4 | 2021 | 6936 | 0.140 |
Why?
|
| Cell Differentiation | 6 | 2018 | 1610 | 0.140 |
Why?
|
| Dietary Sugars | 1 | 2018 | 8 | 0.140 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2018 | 12 | 0.140 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2020 | 269 | 0.130 |
Why?
|
| Pregnancy | 2 | 2022 | 3148 | 0.130 |
Why?
|
| Hepatitis C | 1 | 2020 | 182 | 0.130 |
Why?
|
| Epithelial Cells | 3 | 2018 | 700 | 0.130 |
Why?
|
| Feeding Behavior | 1 | 2020 | 337 | 0.130 |
Why?
|
| Mutation | 1 | 2009 | 4266 | 0.130 |
Why?
|
| Bone Density | 1 | 2019 | 237 | 0.130 |
Why?
|
| Mass Screening | 1 | 2022 | 711 | 0.130 |
Why?
|
| Enzyme Activation | 4 | 2005 | 672 | 0.130 |
Why?
|
| Adult | 9 | 2022 | 27953 | 0.130 |
Why?
|
| Binding Sites | 2 | 2010 | 1128 | 0.130 |
Why?
|
| Tissue Distribution | 3 | 2006 | 290 | 0.120 |
Why?
|
| Obesity, Morbid | 1 | 2019 | 244 | 0.120 |
Why?
|
| CLOCK Proteins | 1 | 2016 | 13 | 0.120 |
Why?
|
| PPAR gamma | 2 | 2009 | 75 | 0.120 |
Why?
|
| Rats, Wistar | 4 | 2012 | 300 | 0.120 |
Why?
|
| Protein Binding | 4 | 2015 | 1528 | 0.120 |
Why?
|
| Oncogene Protein v-akt | 1 | 2016 | 21 | 0.120 |
Why?
|
| Lipolysis | 2 | 2013 | 24 | 0.120 |
Why?
|
| Lung Neoplasms | 1 | 2009 | 2368 | 0.120 |
Why?
|
| Glucocorticoids | 2 | 2009 | 362 | 0.120 |
Why?
|
| Toluidines | 2 | 2013 | 18 | 0.110 |
Why?
|
| Lysophospholipids | 1 | 2016 | 67 | 0.110 |
Why?
|
| Subcutaneous Fat | 1 | 2015 | 21 | 0.110 |
Why?
|
| Glucose Tolerance Test | 2 | 2013 | 233 | 0.110 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 2002 | 85 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2018 | 1243 | 0.110 |
Why?
|
| Up-Regulation | 3 | 2021 | 729 | 0.110 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 3 | 2010 | 26 | 0.110 |
Why?
|
| Stress, Psychological | 1 | 2018 | 343 | 0.110 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 1 | 2014 | 32 | 0.110 |
Why?
|
| Treatment Outcome | 2 | 2019 | 9108 | 0.110 |
Why?
|
| Tyrosine | 2 | 2022 | 131 | 0.100 |
Why?
|
| Glucose Intolerance | 1 | 2014 | 100 | 0.100 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 1993 | 21 | 0.100 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 590 | 0.100 |
Why?
|
| Tissue Adhesions | 1 | 2013 | 53 | 0.100 |
Why?
|
| Stem Cells | 2 | 2020 | 386 | 0.100 |
Why?
|
| Pituitary Gland | 1 | 2013 | 116 | 0.100 |
Why?
|
| Disease Models, Animal | 5 | 2021 | 2491 | 0.100 |
Why?
|
| NADPH Oxidases | 1 | 2013 | 85 | 0.100 |
Why?
|
| Protein Kinases | 2 | 1993 | 210 | 0.090 |
Why?
|
| Social Isolation | 1 | 2013 | 71 | 0.090 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2012 | 9 | 0.090 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 159 | 0.090 |
Why?
|
| Mitochondria, Liver | 1 | 2012 | 29 | 0.090 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2012 | 69 | 0.090 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2012 | 26 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2012 | 13 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 885 | 0.090 |
Why?
|
| Glutathione Transferase | 2 | 2009 | 115 | 0.090 |
Why?
|
| Polysomnography | 1 | 2012 | 153 | 0.090 |
Why?
|
| Flavonoids | 1 | 2012 | 85 | 0.090 |
Why?
|
| Cross-Over Studies | 1 | 2012 | 390 | 0.090 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2009 | 554 | 0.090 |
Why?
|
| Biomarkers | 2 | 2020 | 1912 | 0.090 |
Why?
|
| Cell Nucleus | 2 | 2013 | 602 | 0.080 |
Why?
|
| Mitochondrial Proteins | 1 | 2012 | 128 | 0.080 |
Why?
|
| Immunoblotting | 2 | 2009 | 273 | 0.080 |
Why?
|
| Fatty Acid-Binding Proteins | 2 | 2011 | 25 | 0.080 |
Why?
|
| Informed Consent | 1 | 2013 | 277 | 0.080 |
Why?
|
| Middle Aged | 6 | 2021 | 27620 | 0.080 |
Why?
|
| Transfection | 2 | 2009 | 878 | 0.080 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2010 | 5 | 0.080 |
Why?
|
| Receptors, Calcitriol | 1 | 2011 | 131 | 0.080 |
Why?
|
| Calorimetry, Indirect | 1 | 2010 | 13 | 0.080 |
Why?
|
| Immunohistochemistry | 3 | 2016 | 1790 | 0.080 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2010 | 67 | 0.080 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2010 | 84 | 0.080 |
Why?
|
| Sympathetic Nervous System | 1 | 2010 | 99 | 0.080 |
Why?
|
| Food Industry | 1 | 2010 | 2 | 0.080 |
Why?
|
| Phthalic Acids | 1 | 2009 | 4 | 0.080 |
Why?
|
| Nuclear Proteins | 2 | 2005 | 740 | 0.080 |
Why?
|
| Endrin | 1 | 2009 | 2 | 0.080 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2009 | 30 | 0.080 |
Why?
|
| Phenols | 1 | 2009 | 41 | 0.080 |
Why?
|
| Pheochromocytoma | 1 | 1990 | 53 | 0.080 |
Why?
|
| Benzhydryl Compounds | 1 | 2009 | 46 | 0.080 |
Why?
|
| Luciferases | 1 | 2009 | 129 | 0.080 |
Why?
|
| RNA, Messenger | 2 | 2013 | 2019 | 0.070 |
Why?
|
| Blood Proteins | 1 | 2009 | 145 | 0.070 |
Why?
|
| Blood Glucose | 1 | 2013 | 868 | 0.070 |
Why?
|
| Prednisone | 1 | 2009 | 242 | 0.070 |
Why?
|
| Genes, Reporter | 1 | 2009 | 275 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 3479 | 0.070 |
Why?
|
| Body Weight | 1 | 2010 | 449 | 0.070 |
Why?
|
| Lipogenesis | 3 | 2013 | 25 | 0.070 |
Why?
|
| RNA Interference | 2 | 2007 | 379 | 0.070 |
Why?
|
| Genetic Vectors | 1 | 2010 | 422 | 0.070 |
Why?
|
| Prognosis | 1 | 2016 | 3913 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2007 | 215 | 0.070 |
Why?
|
| Mutation, Missense | 1 | 2010 | 296 | 0.070 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2009 | 149 | 0.070 |
Why?
|
| Environment | 1 | 2009 | 230 | 0.070 |
Why?
|
| Health Policy | 1 | 2010 | 207 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 1923 | 0.070 |
Why?
|
| Cattle | 2 | 2002 | 394 | 0.070 |
Why?
|
| Microbiota | 1 | 2013 | 425 | 0.070 |
Why?
|
| Radiopharmaceuticals | 1 | 2009 | 203 | 0.070 |
Why?
|
| Tumor Burden | 2 | 2020 | 321 | 0.070 |
Why?
|
| Pyruvic Acid | 1 | 2007 | 12 | 0.060 |
Why?
|
| Mice, Knockout | 3 | 2021 | 2121 | 0.060 |
Why?
|
| Lipids | 1 | 2008 | 278 | 0.060 |
Why?
|
| ROC Curve | 1 | 2009 | 775 | 0.060 |
Why?
|
| Phosphorylase a | 1 | 2006 | 1 | 0.060 |
Why?
|
| Sleep | 1 | 2010 | 448 | 0.060 |
Why?
|
| Mice, Inbred Strains | 1 | 2006 | 279 | 0.060 |
Why?
|
| Kinetics | 2 | 2003 | 1470 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 2 | 2003 | 1025 | 0.060 |
Why?
|
| 1,4-alpha-Glucan Branching Enzyme | 1 | 2006 | 1 | 0.060 |
Why?
|
| Glycogen Debranching Enzyme System | 1 | 2006 | 3 | 0.060 |
Why?
|
| Radiographic Image Enhancement | 1 | 2008 | 449 | 0.060 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2006 | 18 | 0.060 |
Why?
|
| Phenotype | 2 | 2020 | 2543 | 0.060 |
Why?
|
| RNA | 1 | 2010 | 572 | 0.060 |
Why?
|
| Adenoma | 1 | 2008 | 258 | 0.060 |
Why?
|
| Pyrones | 1 | 2005 | 8 | 0.060 |
Why?
|
| Solutions | 1 | 2005 | 84 | 0.060 |
Why?
|
| Cell Proliferation | 3 | 2018 | 1735 | 0.060 |
Why?
|
| Vanadates | 1 | 2005 | 32 | 0.060 |
Why?
|
| Genetic Testing | 1 | 2009 | 565 | 0.060 |
Why?
|
| Repressor Proteins | 2 | 2009 | 443 | 0.060 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2006 | 46 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2012 | 1260 | 0.060 |
Why?
|
| Glucokinase | 2 | 2004 | 61 | 0.060 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2008 | 461 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2015 | 7073 | 0.060 |
Why?
|
| Melanocytes | 1 | 2005 | 60 | 0.060 |
Why?
|
| Neural Crest | 1 | 2005 | 33 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2005 | 306 | 0.050 |
Why?
|
| Deoxyglucose | 1 | 2004 | 39 | 0.050 |
Why?
|
| Phosphorylases | 1 | 2004 | 4 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2009 | 629 | 0.050 |
Why?
|
| Extracellular Fluid | 1 | 2004 | 26 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 1715 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2005 | 192 | 0.050 |
Why?
|
| Drug Synergism | 1 | 2004 | 315 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2006 | 555 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 282 | 0.050 |
Why?
|
| Algorithms | 2 | 2009 | 1954 | 0.050 |
Why?
|
| Oligomycins | 1 | 2003 | 5 | 0.050 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2003 | 53 | 0.050 |
Why?
|
| Antimycin A | 1 | 2003 | 13 | 0.050 |
Why?
|
| Adenylate Kinase | 1 | 2003 | 14 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2009 | 1233 | 0.050 |
Why?
|
| Uridine Diphosphate Glucose | 1 | 2003 | 2 | 0.050 |
Why?
|
| Protein Phosphatase 2 | 1 | 2003 | 17 | 0.050 |
Why?
|
| Islets of Langerhans | 2 | 2004 | 557 | 0.050 |
Why?
|
| Indicators and Reagents | 1 | 2003 | 69 | 0.050 |
Why?
|
| Methionine | 1 | 2003 | 64 | 0.050 |
Why?
|
| Cyclic AMP | 3 | 2004 | 276 | 0.050 |
Why?
|
| Appetite | 1 | 2022 | 21 | 0.050 |
Why?
|
| Muscle Denervation | 1 | 2002 | 3 | 0.050 |
Why?
|
| Ghrelin | 1 | 2022 | 27 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 2889 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2005 | 665 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2003 | 361 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2022 | 122 | 0.050 |
Why?
|
| Rabbits | 1 | 2003 | 613 | 0.050 |
Why?
|
| Cysteine | 1 | 2003 | 145 | 0.050 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2022 | 101 | 0.040 |
Why?
|
| Electrons | 1 | 2002 | 51 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2004 | 439 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2002 | 261 | 0.040 |
Why?
|
| Antibodies | 1 | 2003 | 347 | 0.040 |
Why?
|
| Biological Transport | 1 | 2002 | 399 | 0.040 |
Why?
|
| Models, Chemical | 1 | 2002 | 184 | 0.040 |
Why?
|
| Dexamethasone | 2 | 2015 | 311 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2002 | 490 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 2003 | 373 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2020 | 10186 | 0.040 |
Why?
|
| Oxidation-Reduction | 2 | 2012 | 410 | 0.040 |
Why?
|
| Germ-Free Life | 1 | 2020 | 83 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 1115 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 347 | 0.040 |
Why?
|
| Time Factors | 3 | 2004 | 5405 | 0.040 |
Why?
|
| Regional Blood Flow | 1 | 2020 | 186 | 0.040 |
Why?
|
| Ohio | 1 | 2020 | 42 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 639 | 0.040 |
Why?
|
| Ileum | 1 | 2020 | 167 | 0.040 |
Why?
|
| Metagenomics | 1 | 2020 | 100 | 0.040 |
Why?
|
| Cell Polarity | 1 | 2020 | 118 | 0.040 |
Why?
|
| Adolescent | 1 | 2012 | 9610 | 0.040 |
Why?
|
| Electron Spin Resonance Spectroscopy | 1 | 2002 | 324 | 0.040 |
Why?
|
| Proteins | 1 | 2005 | 800 | 0.040 |
Why?
|
| Metagenome | 1 | 2020 | 116 | 0.040 |
Why?
|
| Organ Size | 1 | 2020 | 361 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2020 | 259 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2020 | 300 | 0.040 |
Why?
|
| Mitochondria | 1 | 2003 | 612 | 0.040 |
Why?
|
| Colforsin | 2 | 2001 | 68 | 0.040 |
Why?
|
| Cell Line | 1 | 2003 | 2459 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2020 | 572 | 0.040 |
Why?
|
| Mice, Mutant Strains | 2 | 2011 | 219 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2008 | 2592 | 0.030 |
Why?
|
| Kidney | 1 | 2003 | 1110 | 0.030 |
Why?
|
| Ligands | 2 | 2013 | 476 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 270 | 0.030 |
Why?
|
| Biodiversity | 1 | 2020 | 239 | 0.030 |
Why?
|
| Random Allocation | 1 | 2018 | 307 | 0.030 |
Why?
|
| Weaning | 1 | 2017 | 26 | 0.030 |
Why?
|
| United States | 1 | 2010 | 7645 | 0.030 |
Why?
|
| Thiazolidinediones | 2 | 2009 | 77 | 0.030 |
Why?
|
| Receptors, Thyroid Hormone | 2 | 2009 | 158 | 0.030 |
Why?
|
| Logistic Models | 1 | 2020 | 1246 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 608 | 0.030 |
Why?
|
| Prevalence | 1 | 2020 | 1322 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2016 | 103 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2011 | 959 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 139 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 1164 | 0.030 |
Why?
|
| Aged | 2 | 2009 | 20469 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2016 | 413 | 0.030 |
Why?
|
| Dermatitis, Occupational | 1 | 1993 | 2 | 0.030 |
Why?
|
| Rubber | 1 | 1993 | 5 | 0.030 |
Why?
|
| Gloves, Surgical | 1 | 1993 | 7 | 0.030 |
Why?
|
| Glucose-6-Phosphate | 2 | 2004 | 3 | 0.030 |
Why?
|
| Ionomycin | 1 | 1993 | 19 | 0.030 |
Why?
|
| Calcimycin | 1 | 1993 | 32 | 0.030 |
Why?
|
| Crohn Disease | 1 | 2020 | 808 | 0.030 |
Why?
|
| Peritoneal Cavity | 1 | 2013 | 19 | 0.030 |
Why?
|
| Carbachol | 1 | 1993 | 35 | 0.030 |
Why?
|
| Bradykinin | 1 | 1993 | 44 | 0.030 |
Why?
|
| Caloric Tests | 1 | 2013 | 6 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1993 | 57 | 0.020 |
Why?
|
| Thionucleotides | 1 | 1993 | 54 | 0.020 |
Why?
|
| PC12 Cells | 1 | 1993 | 111 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1993 | 121 | 0.020 |
Why?
|
| Safflower Oil | 1 | 2013 | 7 | 0.020 |
Why?
|
| Colitis, Ulcerative | 1 | 2020 | 800 | 0.020 |
Why?
|
| Hypersensitivity, Immediate | 1 | 1993 | 64 | 0.020 |
Why?
|
| Calmodulin | 1 | 1993 | 50 | 0.020 |
Why?
|
| Gonads | 1 | 2013 | 18 | 0.020 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2013 | 48 | 0.020 |
Why?
|
| Nursing Staff, Hospital | 1 | 1993 | 44 | 0.020 |
Why?
|
| Hyaluronic Acid | 1 | 2013 | 46 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 1993 | 115 | 0.020 |
Why?
|
| Milk | 1 | 2013 | 56 | 0.020 |
Why?
|
| Cytosol | 1 | 1993 | 192 | 0.020 |
Why?
|
| Corticosterone | 1 | 2013 | 35 | 0.020 |
Why?
|
| Response Elements | 1 | 2013 | 65 | 0.020 |
Why?
|
| Food | 1 | 2013 | 92 | 0.020 |
Why?
|
| Medical Staff, Hospital | 1 | 1993 | 104 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 367 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 891 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2012 | 70 | 0.020 |
Why?
|
| Biological Transport, Active | 1 | 2011 | 99 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2012 | 238 | 0.020 |
Why?
|
| Feces | 1 | 2013 | 360 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2012 | 106 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2013 | 407 | 0.020 |
Why?
|
| Insulin-Secreting Cells | 1 | 2014 | 441 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2011 | 278 | 0.020 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2010 | 7 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2013 | 467 | 0.020 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1990 | 14 | 0.020 |
Why?
|
| Elongation Factor 2 Kinase | 1 | 1990 | 7 | 0.020 |
Why?
|
| Locomotion | 1 | 2011 | 144 | 0.020 |
Why?
|
| Colon | 1 | 2013 | 540 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2010 | 123 | 0.020 |
Why?
|
| Computational Biology | 1 | 2013 | 578 | 0.020 |
Why?
|
| Heterozygote | 1 | 2010 | 381 | 0.020 |
Why?
|
| Bacteria | 1 | 2013 | 509 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2013 | 1354 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 269 | 0.020 |
Why?
|
| Down-Regulation | 1 | 1990 | 523 | 0.020 |
Why?
|
| Plasmids | 1 | 2009 | 272 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2009 | 578 | 0.020 |
Why?
|
| DNA Primers | 1 | 2009 | 528 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 331 | 0.020 |
Why?
|
| Apoptosis | 1 | 2013 | 1719 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2010 | 752 | 0.020 |
Why?
|
| Rats, Zucker | 1 | 2006 | 38 | 0.020 |
Why?
|
| Receptors, Leptin | 1 | 2006 | 33 | 0.020 |
Why?
|
| Wnt3 Protein | 1 | 2005 | 13 | 0.010 |
Why?
|
| Wnt1 Protein | 1 | 2005 | 27 | 0.010 |
Why?
|
| Wnt3A Protein | 1 | 2005 | 23 | 0.010 |
Why?
|
| Wnt-5a Protein | 1 | 2005 | 10 | 0.010 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2005 | 24 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 2005 | 124 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2013 | 1690 | 0.010 |
Why?
|
| Phosphorylase Kinase | 1 | 2004 | 1 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2006 | 292 | 0.010 |
Why?
|
| Wnt Proteins | 1 | 2005 | 127 | 0.010 |
Why?
|
| Amides | 1 | 2004 | 54 | 0.010 |
Why?
|
| CREB-Binding Protein | 1 | 2004 | 16 | 0.010 |
Why?
|
| Gluconates | 1 | 2004 | 14 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 238 | 0.010 |
Why?
|
| Glucagon | 1 | 2004 | 114 | 0.010 |
Why?
|
| Second Messenger Systems | 1 | 2004 | 39 | 0.010 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2004 | 64 | 0.010 |
Why?
|
| Muscle, Smooth | 1 | 2005 | 300 | 0.010 |
Why?
|
| Muscles | 1 | 2004 | 184 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2005 | 320 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2003 | 140 | 0.010 |
Why?
|
| Brain | 1 | 1993 | 2373 | 0.010 |
Why?
|
| Indoles | 1 | 2004 | 301 | 0.010 |
Why?
|
| Hexokinase | 1 | 2002 | 22 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 982 | 0.010 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2002 | 69 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 2718 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 726 | 0.010 |
Why?
|
| Reference Values | 1 | 2002 | 608 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2005 | 657 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2001 | 293 | 0.010 |
Why?
|
| Angioedema | 1 | 1993 | 4 | 0.010 |
Why?
|
| Bronchial Spasm | 1 | 1993 | 12 | 0.010 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 1993 | 9 | 0.010 |
Why?
|
| Anaphylaxis | 1 | 1993 | 30 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 1993 | 148 | 0.010 |
Why?
|
| Emergencies | 1 | 1993 | 122 | 0.010 |
Why?
|